Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening by metastasis only in extremely rare cases. According to the American Cancer Society, BCCs constitute around 80% of all non-melanoma skin cancers. Australia has been found to have the highest rate of basal cell carcinoma across the globe. Exposure to ultraviolet radiation is considered as the major cause behind BCC. Use of immunosuppressant drugs further enhance the chances of BCC as the immune system is compromised. White people are more vulnerable to BCC comparatively, according to a research published in the British Medical Journal. The symptoms of BCCs include waxy papules (slightly transparent bump) with pearly appearance and central depression and bleeding from the papules.
The increase in geriatric population, giving rise to numerous skin diseases, such as actinic keratosis and other non-melanoma skin malignancies, is another important factor that has been fueling the demand for basal cell carcinoma treatment substantially. In addition to these, the market is expected to gain considerably from the changing lifestyle of people in developing economies over the coming years as it is anticipated to drive demand for better disease treatments, which in turn, is likely to provide lucrative opportunities for the companies operating in the global basal cell carcinoma treatment market.
Market Analysis and Insights: Global Basal Cell Carcinoma Therapeutics Market
The global Basal Cell Carcinoma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Basal Cell Carcinoma Therapeutics Scope and Market Size
Basal Cell Carcinoma Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Basal Cell Carcinoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Sun Pharmaceuticals
Bausch Health
Mylan
F. Hoffmann-La Roche
Merck
...
Basal Cell Carcinoma Therapeutics Breakdown Data by Type
Surgery
Radiation Therapy
Photodynamic Therapy
Drugs
Basal Cell Carcinoma Therapeutics Breakdown Data by Application
Retail Pharmacies
Hospitals Pharmacies
Cancer Research Institutes
The increase in geriatric population, giving rise to numerous skin diseases, such as actinic keratosis and other non-melanoma skin malignancies, is another important factor that has been fueling the demand for basal cell carcinoma treatment substantially. In addition to these, the market is expected to gain considerably from the changing lifestyle of people in developing economies over the coming years as it is anticipated to drive demand for better disease treatments, which in turn, is likely to provide lucrative opportunities for the companies operating in the global basal cell carcinoma treatment market.
Market Analysis and Insights: Global Basal Cell Carcinoma Therapeutics Market
The global Basal Cell Carcinoma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Basal Cell Carcinoma Therapeutics Scope and Market Size
Basal Cell Carcinoma Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Basal Cell Carcinoma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Sun Pharmaceuticals
Bausch Health
Mylan
F. Hoffmann-La Roche
Merck
...
Basal Cell Carcinoma Therapeutics Breakdown Data by Type
Surgery
Radiation Therapy
Photodynamic Therapy
Drugs
Basal Cell Carcinoma Therapeutics Breakdown Data by Application
Retail Pharmacies
Hospitals Pharmacies
Cancer Research Institutes
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Basal Cell Carcinoma Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Basal Cell Carcinoma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Radiation Therapy
1.4.4 Photodynamic Therapy
1.4.5 Drugs
1.5 Market by Application
1.5.1 Global Basal Cell Carcinoma Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Retail Pharmacies
1.5.3 Hospitals Pharmacies
1.5.4 Cancer Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Basal Cell Carcinoma Therapeutics Market Perspective (2015-2026)
2.2 Global Basal Cell Carcinoma Therapeutics Growth Trends by Regions
2.2.1 Basal Cell Carcinoma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Basal Cell Carcinoma Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Basal Cell Carcinoma Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Basal Cell Carcinoma Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Basal Cell Carcinoma Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Basal Cell Carcinoma Therapeutics Players by Market Size
3.1.1 Global Top Basal Cell Carcinoma Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Basal Cell Carcinoma Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Basal Cell Carcinoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Basal Cell Carcinoma Therapeutics Market Concentration Ratio
3.2.1 Global Basal Cell Carcinoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Basal Cell Carcinoma Therapeutics Revenue in 2019
3.3 Basal Cell Carcinoma Therapeutics Key Players Head office and Area Served
3.4 Key Players Basal Cell Carcinoma Therapeutics Product Solution and Service
3.5 Date of Enter into Basal Cell Carcinoma Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Basal Cell Carcinoma Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Basal Cell Carcinoma Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
5.2 Global Basal Cell Carcinoma Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
6.2 Basal Cell Carcinoma Therapeutics Key Players in North America (2019-2020)
6.3 North America Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
6.4 North America Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
7.2 Basal Cell Carcinoma Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
7.4 Europe Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
8.2 Basal Cell Carcinoma Therapeutics Key Players in China (2019-2020)
8.3 China Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
8.4 China Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
9.2 Basal Cell Carcinoma Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
9.4 Japan Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
10.2 Basal Cell Carcinoma Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
11.2 Basal Cell Carcinoma Therapeutics Key Players in India (2019-2020)
11.3 India Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
11.4 India Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
12.2 Basal Cell Carcinoma Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sun Pharmaceuticals
13.1.1 Sun Pharmaceuticals Company Details
13.1.2 Sun Pharmaceuticals Business Overview
13.1.3 Sun Pharmaceuticals Basal Cell Carcinoma Therapeutics Introduction
13.1.4 Sun Pharmaceuticals Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020))
13.1.5 Sun Pharmaceuticals Recent Development
13.2 Bausch Health
13.2.1 Bausch Health Company Details
13.2.2 Bausch Health Business Overview
13.2.3 Bausch Health Basal Cell Carcinoma Therapeutics Introduction
13.2.4 Bausch Health Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)
13.2.5 Bausch Health Recent Development
13.3 Mylan
13.3.1 Mylan Company Details
13.3.2 Mylan Business Overview
13.3.3 Mylan Basal Cell Carcinoma Therapeutics Introduction
13.3.4 Mylan Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)
13.3.5 Mylan Recent Development
13.4 F. Hoffmann-La Roche
13.4.1 F. Hoffmann-La Roche Company Details
13.4.2 F. Hoffmann-La Roche Business Overview
13.4.3 F. Hoffmann-La Roche Basal Cell Carcinoma Therapeutics Introduction
13.4.4 F. Hoffmann-La Roche Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)
13.4.5 F. Hoffmann-La Roche Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Basal Cell Carcinoma Therapeutics Introduction
13.5.4 Merck Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)
13.5.5 Merck Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Basal Cell Carcinoma Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Basal Cell Carcinoma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Radiation Therapy
1.4.4 Photodynamic Therapy
1.4.5 Drugs
1.5 Market by Application
1.5.1 Global Basal Cell Carcinoma Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Retail Pharmacies
1.5.3 Hospitals Pharmacies
1.5.4 Cancer Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Basal Cell Carcinoma Therapeutics Market Perspective (2015-2026)
2.2 Global Basal Cell Carcinoma Therapeutics Growth Trends by Regions
2.2.1 Basal Cell Carcinoma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Basal Cell Carcinoma Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Basal Cell Carcinoma Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Basal Cell Carcinoma Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Basal Cell Carcinoma Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Basal Cell Carcinoma Therapeutics Players by Market Size
3.1.1 Global Top Basal Cell Carcinoma Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Basal Cell Carcinoma Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Basal Cell Carcinoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Basal Cell Carcinoma Therapeutics Market Concentration Ratio
3.2.1 Global Basal Cell Carcinoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Basal Cell Carcinoma Therapeutics Revenue in 2019
3.3 Basal Cell Carcinoma Therapeutics Key Players Head office and Area Served
3.4 Key Players Basal Cell Carcinoma Therapeutics Product Solution and Service
3.5 Date of Enter into Basal Cell Carcinoma Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Basal Cell Carcinoma Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Basal Cell Carcinoma Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
5.2 Global Basal Cell Carcinoma Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
6.2 Basal Cell Carcinoma Therapeutics Key Players in North America (2019-2020)
6.3 North America Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
6.4 North America Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
7.2 Basal Cell Carcinoma Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
7.4 Europe Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
8.2 Basal Cell Carcinoma Therapeutics Key Players in China (2019-2020)
8.3 China Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
8.4 China Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
9.2 Basal Cell Carcinoma Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
9.4 Japan Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
10.2 Basal Cell Carcinoma Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
11.2 Basal Cell Carcinoma Therapeutics Key Players in India (2019-2020)
11.3 India Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
11.4 India Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Basal Cell Carcinoma Therapeutics Market Size (2015-2020)
12.2 Basal Cell Carcinoma Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Basal Cell Carcinoma Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Basal Cell Carcinoma Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sun Pharmaceuticals
13.1.1 Sun Pharmaceuticals Company Details
13.1.2 Sun Pharmaceuticals Business Overview
13.1.3 Sun Pharmaceuticals Basal Cell Carcinoma Therapeutics Introduction
13.1.4 Sun Pharmaceuticals Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020))
13.1.5 Sun Pharmaceuticals Recent Development
13.2 Bausch Health
13.2.1 Bausch Health Company Details
13.2.2 Bausch Health Business Overview
13.2.3 Bausch Health Basal Cell Carcinoma Therapeutics Introduction
13.2.4 Bausch Health Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)
13.2.5 Bausch Health Recent Development
13.3 Mylan
13.3.1 Mylan Company Details
13.3.2 Mylan Business Overview
13.3.3 Mylan Basal Cell Carcinoma Therapeutics Introduction
13.3.4 Mylan Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)
13.3.5 Mylan Recent Development
13.4 F. Hoffmann-La Roche
13.4.1 F. Hoffmann-La Roche Company Details
13.4.2 F. Hoffmann-La Roche Business Overview
13.4.3 F. Hoffmann-La Roche Basal Cell Carcinoma Therapeutics Introduction
13.4.4 F. Hoffmann-La Roche Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)
13.4.5 F. Hoffmann-La Roche Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Basal Cell Carcinoma Therapeutics Introduction
13.5.4 Merck Revenue in Basal Cell Carcinoma Therapeutics Business (2015-2020)
13.5.5 Merck Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
